Distinct Hematopoietic Progenitor Compartments Are Delineated by the Expression of Aldehyde Dehydrogenase and CD34

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2005 Mar 26

PMID 15790790

Citations 42

Authors

Robert W Storms

Patrick D Green

Kristine M Safford

Donna Niedzwiecki

Christopher R Cogle

O Michael Colvin

Nelson J Chao

Henry E Rice

Clayton A Smith

Affiliations

Soon will be listed here.

Abstract

A broad range of hematopoietic stem cells and progenitors reside within a fraction of umbilical cord blood (UCB) that exhibits low light scatter properties (SSC(lo)) and high expression of aldehyde dehydrogenase (ALDH(br)). Many SSC(lo) ALDH(br) cells coexpress CD34; however, other cells express either ALDH or CD34. To investigate the developmental potential of these cell subsets, purified ALDH(br) CD34+, ALDH(neg) CD34+, and ALDH(br) CD34(neg) UCB cells were characterized within a variety of in vivo and in vitro assays. Primitive progenitors capable of multilineage development were monitored in long- and short-term repopulation assays performed on nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice, and in primary and secondary long-term culture assays. These progenitors were highly enriched within the ALDH(br) CD34+ fraction. This cell fraction also enriched short-term myeloid progenitors that were detected in vitro. By comparison, ALDH(neg) CD34+ cells contained few primitive progenitors and had diminished short-term myeloid potential but exhibited enhanced short-term natural killer (NK) cell development in vitro. The ALDH(br) CD34(neg) cells were not efficiently supported by any of the assays used. These studies suggested that in particular the expression of ALDH delineated distinct CD34+ stem cell and progenitor compartments. The differential expression of ALDH may provide a means to explore normal and malignant processes associated with myeloid and lymphoid development.

Citing Articles

Distinct Phenotypic and Molecular Characteristics of CD34 and CD34 Hematopoietic Stem/Progenitor Cell Subsets in Cord Blood and Bone Marrow Samples: Implications for Clinical Applications.

Gaafar A, Hamza F, Yousif R, Shinwari Z, Alotaibi A, Iqniebi A Diagnostics (Basel). 2025; 15(4).

PMID: 40002599 PMC: 11853955. DOI: 10.3390/diagnostics15040447.

Activity-Based Bioluminescent Logic-Gate Probe Reveals Crosstalk Between the Inflammatory Tumor Microenvironment and ALDH1A1 in Cancer Cells.

Swartchick C, Dirak M, Wenger L, Tapia Hernandez R, Lee M, Chan J JACS Au. 2025; 5(1):320-331.

PMID: 39886570 PMC: 11775703. DOI: 10.1021/jacsau.4c01001.

The authors reply: Comment on: "Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients" by Etienne et al.

Etienne J, Joanne P, Catelain C, Riveron S, Bayer Wildberger A, Lafable J J Cachexia Sarcopenia Muscle. 2020; 11(6):1860-1862.

PMID: 32939998 PMC: 7749569. DOI: 10.1002/jcsm.12629.

Hydrodynamic shear-based purification of cancer cells with enhanced tumorigenic potential.

Cermeno E, OMelia M, Han W, Veith A, Barber G, Huang E Integr Biol (Camb). 2020; 12(1):1-11.

PMID: 31965190 PMC: 7036474. DOI: 10.1093/intbio/zyz038.

High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia.

Yang L, Chen W, Dao F, Zhang Y, Wang Y, Chang Y Cancer Med. 2019; 8(12):5459-5467.

PMID: 31364309 PMC: 6745853. DOI: 10.1002/cam4.2422.

References

Akashi K, Traver D, Miyamoto T, Weissman I . A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404(6774):193-7. DOI: 10.1038/35004599. View

Muench M, Cupp J, Polakoff J, Roncarolo M . Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential. Blood. 1994; 83(11):3170-81. View

Hao Q, Zhu J, Price M, Payne K, Barsky L, Crooks G . Identification of a novel, human multilymphoid progenitor in cord blood. Blood. 2001; 97(12):3683-90. DOI: 10.1182/blood.v97.12.3683. View

Gao Z, Fackler M, Leung W, Lumkul R, Ramirez M, Theobald N . Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34- cell preparations. Exp Hematol. 2001; 29(7):910-21. DOI: 10.1016/s0301-472x(01)00654-3. View

Dao M, Arevalo J, Nolta J . Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood. 2002; 101(1):112-8. DOI: 10.1182/blood-2002-01-0025. View

Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y . SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood. 2002; 101(8):2924-31. DOI: 10.1182/blood-2002-09-2782. View

Zanjani E, Almeida-Porada G, Livingston A, Zeng H, Ogawa M . Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. Exp Hematol. 2003; 31(5):406-12. DOI: 10.1016/s0301-472x(03)00051-1. View

Fallon P, Gentry T, Balber A, Boulware D, Janssen W, Smilee R . Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol. 2003; 122(1):99-108. DOI: 10.1046/j.1365-2141.2003.04357.x. View

Cai J, Weiss M, Rao M . In search of "stemness". Exp Hematol. 2004; 32(7):585-98. PMC: 3279197. DOI: 10.1016/j.exphem.2004.03.013. View

10.

Hess D, Meyerrose T, Wirthlin L, Craft T, Herrbrich P, Creer M . Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 2004; 104(6):1648-55. DOI: 10.1182/blood-2004-02-0448. View

11.

Jordan C, Lemischka I . Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 1990; 4(2):220-32. DOI: 10.1101/gad.4.2.220. View

12.

Lemischka I . Clonal, in vivo behavior of the totipotent hematopoietic stem cell. Semin Immunol. 1991; 3(6):349-55. View

13.

Jones R, Barber J, Vala M, Collector M, Kaufmann S, Ludeman S . Assessment of aldehyde dehydrogenase in viable cells. Blood. 1995; 85(10):2742-6. View

14.

Jones R, Collector M, Barber J, Vala M, Fackler M, May W . Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood. 1996; 88(2):487-91. View

15.

Civin C, Trischmann T, Kadan N, Davis J, Noga S, Cohen K . Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol. 1996; 14(8):2224-33. DOI: 10.1200/JCO.1996.14.8.2224. View

16.

Civin C, Almeida-Porada G, Lee M, Olweus J, Terstappen L, Zanjani E . Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood. 1996; 88(11):4102-9. View

17.

Bensinger W, Buckner C, Shannon-Dorcy K, Rowley S, Appelbaum F, Benyunes M . Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood. 1996; 88(11):4132-8. View

18.

Larochelle A, Vormoor J, Hanenberg H, Wang J, Bhatia M, Lapidot T . Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996; 2(12):1329-37. DOI: 10.1038/nm1296-1329. View

19.

Bhatia M, Wang J, Kapp U, Bonnet D, Dick J . Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 1997; 94(10):5320-5. PMC: 24676. DOI: 10.1073/pnas.94.10.5320. View

20.

Moore K, Ema H, Lemischka I . In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood. 1997; 89(12):4337-47. View